Showing results (141-150 of 151) with videos related to
Sort By:
Pageof 16
Controlled Clinical Trials|October 6, 2000
Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on FraudJ Ranstam, M Buyse, S L George, et al.Statistics in Medicine|December 28, 1999
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trialsM Buyse, S L George, S Evans, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer SocietyG Hartung, G Stehle, H Sinn, et al.Klinische Wochenschrift|June 15, 1982
A randomized study of combination chemotherapy (VAC-FMC) with or without immunostimulation by Corynebacterium parvum in metastatic breast cancerD Fritze, R Becher, B Massner, et al.Onkologie|June 4, 2005
Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III studyG Hartung, R-D Hofheinz, Y Dencausse, et al.European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIVL Bergmann, L Maute, G Heil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study GroupE Laack, N Dickgreber, T Müller, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 8, 2006
Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI EuropeS Barlow, A G Renwick, J Kleiner, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2006
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOGD Schadendorf, S Ugurel, B Schuler-Thurner, et al.Environmental Health Perspectives|May 26, 1998
Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congenersD Jung, P A Berg, L Edler, et al.Pageof 16